Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Scand J Gastroenterol ; 38(8): 886-93, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12940444

ABSTRACT

BACKGROUND: Hepatocellular carcinoma (HCC) in persons with liver cirrhosis (LC) arises following hepatitis virus infection. Alcohol may accelerate the risk of development of LC and HCC. Cytochrome p450 2E1 (CYP2E1) oxidizes ethanol to form acetaldehyde and aldehyde dehydrogenase 2 (ALDH2) detoxifies acetaldehyde, which is carcinogenic in humans, and both alcohol-metabolizing enzymes show the genetic polymorphisms in a Japanese population. METHODS: Using polymorphism analysis, we studied the frequency of ALDH2 functional deletion due to the G to A single-bp mutation in exon 12 and CYP2E1 polymorphism in the transcriptional region, both associated with higher levels of acetaldehyde, in 135 patients with LC and/or HCC, including 99 with HCC, and 135 non-cancer controls. The mRNA expression levels of CYP2E1 in the liver were also examined in 55 surgical specimens. RESULTS: The allelic frequency of the homozygous ALDH2 2-2 genotype, coding for the enzyme deletion, was significantly higher compared to that of the homozygous or heterozygous ALDH2 1-1 genotypes in cases with HCC (OR = 5.4, 95% CI 2.1-14.0). There were no differences in the frequencies of specific genotypes of CYP2E1 in cases of HCC, but combined analysis of ALDH2 and CYP2E1 revealed that the odds ratio of occurrence of the C1/C1 homozygosity of CYP2E1 and the ALDH2 2-2 homozygosity was as high as 23.0 (2.9-182). The mRNA levels of CYP2E1 were higher in the liver of patients with the C1/C1 homozygosity of CYP2E1 than in those with other genotypes (P < 0.05). CONCLUSIONS: ALDH2 and CYP2E1 polymorphisms may modify the risk of development of HCC against the background of LC in the Japanese. Polymorphism analysis of alcohol-metabolizing enzymes using molecular techniques may be useful in the risk assessment of liver cancer in patients with hepatitis C virus infection.


Subject(s)
Aldehyde Dehydrogenase/genetics , Cytochrome P-450 CYP2E1/genetics , Hepatitis C/complications , Liver Neoplasms/etiology , Polymorphism, Genetic/genetics , Adult , Aged , Aged, 80 and over , Aldehyde Dehydrogenase, Mitochondrial , Exons/genetics , Female , Hepatitis C Antibodies/blood , Humans , Japan , Liver Cirrhosis/complications , Male , Middle Aged , Mutation/genetics , RNA, Messenger/analysis , Risk Factors , Transcription Initiation Site
2.
J Immunol ; 167(3): 1454-60, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11466365

ABSTRACT

The avian B cell differentiation Ag chB1 is a membrane glycoprotein relative of the mammalian B cell differentiation Ag CD72. Unlike CD72, this C-type lectin is expressed in relatively high levels on immature B cells in the bursa of Fabricius and is down-regulated on mature B cells in the periphery. An immunoreceptor tyrosine-based inhibitory motif in the chB1 cytoplasmic tail suggests a potential regulatory role in intrabursal B cell development. To gain further insight into the selective expression and function of chB1, we determined the genomic organization of chB1 and examined the mechanism of its transcriptional regulation. The 8-exon chB1 gene proved to have very similar organization to that of mouse CD72, further supporting the idea that chB1 is a CD72 relative. As for mouse CD72, the chB1 promoter region lacks a TATA box but contains a conserved initiator element. The 131-bp region (-161 to -30) proximal to the transcriptional start site, which contains a potential early B cell factor binding site, is essential for the B lineage stage-specific transcription of chB1, whereas PU.1 and B cell-specific activator protein/Pax5 have been shown to play important roles in CD72 promoter activity and cell-type specificity. This analysis suggests that differences in transcriptional regulation of these phylogenetically related genes may determine the differences in expression pattern and, therefore, the function of avian chB1 and mammalian CD72 during B cell development.


Subject(s)
Antigens, Differentiation, B-Lymphocyte/chemistry , Antigens, Differentiation, B-Lymphocyte/genetics , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Exons , Introns , Transcription, Genetic/immunology , 5' Untranslated Regions/metabolism , Amino Acid Sequence , Animals , Antigens, CD/chemistry , Antigens, CD/genetics , Antigens, Differentiation, B-Lymphocyte/biosynthesis , Base Sequence , Binding Sites/genetics , Binding Sites/immunology , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Line , Cell Line, Transformed , Chickens , Gene Expression Regulation/immunology , Lectins/chemistry , Lectins/genetics , Lectins, C-Type , Molecular Sequence Data , Promoter Regions, Genetic/immunology , Sequence Analysis, DNA , Transcription Factors/genetics , Transcription Factors/metabolism
4.
J Immunol ; 161(11): 5804-8, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9834055

ABSTRACT

The bursa of Fabricius is a gut-associated lymphoid organ that is essential for the generation of a diversified B cell repertoire in the chicken. We describe here a novel gene preferentially expressed in bursal B cells. The gene encodes an 85-kDa protein, designated BASH (B cell adaptor containing SH2 domain), that contains N-terminal acidic domains with SH2 domain-binding phosphotyrosine-based motifs, a proline-rich domain, and a C-terminal SH2 domain. BASH shows a substantial sequence similarity to SLP-76, an adaptor protein functioning in TCR-signal transduction. BASH becomes tyrosine-phosphorylated with the B cell Ag receptor (BCR) cross-link or by coexpression with Syk and Lyn and associates with signaling molecules including Syk and a putative chicken Shc homologue. Overexpression of BASH results in suppression of the NF-AT activation induced by BCR-cross-linking. These findings suggest that BASH is involved in BCR-mediated signal transduction and could play a critical role in B cell development in the bursa.


Subject(s)
Adaptor Proteins, Signal Transducing , Adaptor Proteins, Vesicular Transport , B-Lymphocytes/metabolism , Bursa of Fabricius/metabolism , Carrier Proteins , Nuclear Proteins , Phosphoproteins/biosynthesis , Signal Transduction/immunology , src Homology Domains/immunology , Amino Acid Sequence , Animals , B-Lymphocytes/immunology , Bursa of Fabricius/cytology , Bursa of Fabricius/immunology , Cell Line , Chickens , DNA, Complementary/isolation & purification , DNA-Binding Proteins/metabolism , Enzyme Precursors/metabolism , Enzyme Precursors/physiology , Humans , Immunoglobulin M/metabolism , Intracellular Signaling Peptides and Proteins , Molecular Sequence Data , NFATC Transcription Factors , Phosphoproteins/genetics , Phosphoproteins/metabolism , Phosphorylation , Protein-Tyrosine Kinases/metabolism , Protein-Tyrosine Kinases/physiology , Proteins/metabolism , RNA, Messenger/biosynthesis , Receptors, Antigen, B-Cell/metabolism , Receptors, Antigen, B-Cell/physiology , Shc Signaling Adaptor Proteins , Src Homology 2 Domain-Containing, Transforming Protein 1 , Syk Kinase , Transcription Factors/metabolism , Tyrosine/metabolism , src-Family Kinases/physiology
5.
Phys Rev Lett ; 64(21): 2515-2518, 1990 May 21.
Article in English | MEDLINE | ID: mdl-10041732
6.
J Antibiot (Tokyo) ; 37(7): 700-5, 1984 Jul.
Article in English | MEDLINE | ID: mdl-6732903

ABSTRACT

A new peptide antibiotic named takaokamycin was isolated from a fermentation broth of Streptomyces sp. AC-1978, a soil isolate. It exhibits antibacterial activity against some Gram-positive bacteria. The molecular weight was found to be 1,130 on the basis of elemental analysis, FD-mass spectrum and 1H and 13C NMR. Acid hydrolysate of takaokamycin contains isoleucine, threonine and unidentified amino acids.


Subject(s)
Anti-Bacterial Agents/isolation & purification , Animals , Antimicrobial Cationic Peptides , Magnetic Resonance Spectroscopy , Mice , Micrococcus/drug effects , Peptides/isolation & purification , Peptides/pharmacology , Spectrophotometry, Infrared , Streptomyces/analysis
7.
J Antibiot (Tokyo) ; 37(5): 494-502, 1984 May.
Article in English | MEDLINE | ID: mdl-6735923

ABSTRACT

The production of tylosin by Streptomyces fradiae KA-427 in a defined medium was inhibited by ammonium ions and by inorganic phosphate. The production of protylonolide, an early lactonic intermediate of tylosin biosynthesis with the same carbon skeleton as tylosin aglycone, by a mutant of strain KA-427 was also reduced by these two kinds of ions. In contrast, the bioconversion of protylonolide to tylosin by another mutant was less susceptible to ammonium ions but was sensitive to inorganic phosphate. The addition of protylonolide to a culture of S. fradiae KA-427 increased the tylosin yield, suggesting that aglycone synthesis is limiting under the conditions used. When L-valine, L-leucine, L-isoleucine, L-threonine, or the corresponding 2-keto acid was added to the culture medium, the protylonolide titer increased. The addition of [14C]valine gave rise to [14C]protylonolide. 13C NMR spectroscopic analysis revealed that iso-butyrate, which is a valine metabolite, was incorporated into protylonolide at the carbons known to originate from propionate and n-butyrate. Taking account of these findings, the regulation of tylosin biosynthesis in S. fradiae by ammonium ion is discussed in relation to amino acid metabolism.


Subject(s)
Amino Acids/pharmacology , Ammonia/pharmacology , Leucomycins/biosynthesis , Phosphates/pharmacology , Streptomyces/metabolism , Butyrates/metabolism , Culture Media , Isobutyrates , Keto Acids/pharmacology , Tylosin , Valine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...